Rikin Kartikbhai Shah
Specialty: Pediatric Hematology-Oncology
Experience
Arnold Palmer Hospital for Children, Orlando Health
Orlando, FL, United States|2022 – Present|Director of Pediatric Bone Marrow Transplantation and Cellular Therapy, Haley Center for Children’s Cancer and Blood Disorders|
University of Oklahoma Health Science Center
Oklahoma City, OK, United States|2018 – 2022|Assistant Professor, Department of Pediatrics, Pediatric Hematology/Oncology|
University of Oklahoma Health Sciences Center
Oklahoma City, OK, United States|2020 – 2022|Interim Director of Pediatric Transplantation and Cellular Therapy, College of Medicine|
University of Oklahoma Health Sciences Center
Oklahoma City, OK, United States|2020 – 2022|Associate Director of Pediatric Hematology/Oncology Fellowship Program, Jimmy Everest Section|
University of Oklahoma Health Sciences Center
Oklahoma City, OK, United States|2020 – 2022|Director of Ambulatory Stem Cell Service, Jimmy Everest Section of Pediatric Hematology/Oncology|
Education
Smt. N.H.L Municipal Medical College
Ahmedabad, India|2003 – 2009|Bachelor of Medicine, Bachelor of Surgery|
Texas Tech University Health Science Center at Amarillo
Amarillo, TX, United States|2011 – 2014|Pediatric Resident, Department of Pediatrics|
University of Oklahoma Health Science Center
Oklahoma City, OK, United States|2014 – 2017|Pediatric Hematology/Oncology Fellow, Department of Pediatrics
Baylor College of Medicine
Houston, TX, United States|2017 – 2018|Pediatric Stem Cell Transplantation Fellow, Department of Pediatric Hematology/Oncology
Research & Publications
Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance
Stenger E, Xiang Y, Wetzel M, Gillespie S, Chellapandian D, Shah R, Arnold SD, Bhatia M, Chaudhury S, Eckrich MJ, Kanter J, Kasow KA, Krajewski J, Nickel RS, Ngwube AI, Olson TS, Rangarajan HG, Wobma H, Guilcher GMT, Horan JT, Krishnamurti L, Shenoy S, Abraham A.|2023|Transplant Cell Ther.|
Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease
Srinivasan A, Bajana S, Pankow A, Yuen CH, Shah RK, Sun XH.|2021|BMC Immunology|
IDH1 mutated acute myeloid leukemia in a child with metaphyseal chondromatosis with D-2-hydroxyglutaric aciduriadisease
Srinivasan A, Zhou Y, Scordino TA, Prabhu SG, Wierenga AM, Simon G, Wierenga KJ, Thompson JC, Shah RK, Sinha A.|2020|Pediatric Hematology and Oncology|
Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis
Borga C, Park G, Foster C, Burroughs-Garcia J, Marchesin M, Shah RK, Hasan A, Ahmed ST, Bresolin S, Batchelor L, Scordino TA, Miles RR, Te Kronnie G, Regens JL, Frazer JK.|2019|Leukemia|
Encephalocraniocutaneous Lipomatosis
Bavle AA, Shah RK, Gross N, Gavula T, Ruiz-Elizalde AR, Wierenga KJ, McNall-Knapp R.|2018|Journal of Pediatric Hematology/Oncology|
A novel homozygous VPS45 p.P468L mutation leading to severe congenital neutropenia with myelofibrosis
Shah RK, Munson M, Wierenga KJ, Pokala HR, Newburger PE, Crawford DF.|2017|Pediatric Blood & Cancer|
Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma
Miles RR, Shah RK, Frazer JK.|2016|British Journal of Haematology|
N-acetylcysteine renoprotection in methotrexate induced nephrotoxicity and its effects on B-cell lymphoma
Singh R, Shah RK, Turner C, Regueira O, Vasylyeva TL.|2015|Indian Journal of Medical and Paediatric Oncology|
N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide
Hanly L, Rieder MJ, Huang SH, Vasylyeva TL, Shah RK, Regueira O, Koren G.|2013|Journal of Population Therapeutics and Clinical Pharmacology|
childifosfamide
Shah RK, Sethi VK, Bridges WJ, Abiodun JO.|2012|Open Journal of Pediatrics|
Onychomadesis secondary to penicillin allergy in a child
Shah RK, Uddin M, Fatunde OJ.|2012|The Journal of Pediatrics|
Two patients with an anti-N-methyl-D-aspartate receptor antibody syndrome-like presentation and negative results of testing for autoantibodies
Shah RK, Veerapandiyan A, Winchester S, Gallentine W, Mikati MA.|2011|Pediatric Neurology|
Preservation of Pulmonary Function Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study
Horan F, Bendiak G, Abraham A, Liu K, Gillespie S, Chellapandian D, Shah RK, Bhatia M, Chaudhury S, Eckrich M, Jaroscak J, Kasow K, Krajewski J, Nguwube A, Horan J, Krishnamurti L, Shenoy S, Guilcher G, Stenger E.|2023|Transplantation and Cellular Therapy|
Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study
Stenger E, John TD, Chellapandian D, Shah RK, Gillespie S, Xiang Y, Liu K, Bhatia M, Guilcher GMT, Jaroscak J, Kasow KA, Krajewski J, Ngwube AI, Rangarajan HG, Horan JT, Krishnamurti L, Shenoy S, Abraham A.|2023|Blood|
Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study
John TD, Chellapandian D, Shah RK, Gillespie S, Liu K, Xiang Y, Bhatia M, Chaudhury S, Eckrich MJ, Guilcher GMT, Jaroscak J, Kasow KA, Krajewski J, Ngwube AI, Olson TS, Rangarajan HG, Horan JT, Krishnamurti L, Shenoy S, Abraham A, Stenger E.|2023|Blood|
Recovery of innate lymphoid cells after allogeneic stem cell transplant: A single institution pilot study
Srinivasan A, Shah RK.|2020|The Journal of Immunology|
Retrospective Review of Use of Individualized Dosing of Rabbit Anti-Thymocyte Globulin on Outcomes in Pediatric Post Allogeneic Stem Cell Transplant Patients
Srinivasan A, Shah RK, Anderson M, Stubblefield A, Admiraal R, Boelens J-J, Crawford DF.|2019|BBMT|
Decreasing the Rate of Asparaginase Reactions due to Hyperammonemia
McNall-Knapp R, Sims K, Shah RK, Mazzone S, Peek L, Howard S.|2017|Pediatric Blood and Cancer|
Certifications/Awards/Recognitions
Presbyterian Health Foundation Pediatric Fellow
Presbyterian Health Foundation/Children’s Hospital Foundation|2015-2017|
Outstanding Poster Presentation
OUHSC Pediatric Research Day|2017|
Outstanding Poster Presentation
OUHSC Pediatric Research Day|2016|
Dean’s Scholarly Achievement Award for Peer-Reviewed Scientific Publication
Texas Tech University Health Science Center at Amarillo||2014|
Dean’s Scholarly Achievement Award for Peer-Reviewed PublicationScientifc Publication
Texas Tech University Health Science Center at Amarillo|2013|
First Place in Poster Presentation
Texas Tech University Health Science Center at Amarillo|2013|
Travel Grant Award for Kidney Week
American Society of Nephrology|2012|
Dean’s Scholarly Achievement Award for Peer-Reviewed Scientific Publication
Texas Tech University Health Science Center at Amarillo|2012|
BOARD AND PRACTICE CERTIFICATION
American Board of Pediatrics, Pediatric Hematology-Oncology
American Board of Pediatrics|2019 – Present|
American Board of Pediatrics, Pediatrics
American Board of Pediatrics|2014 – Present|
LICENSE
Florida
Medical License|2021 – Present|
Oklahoma
Medical License|2014 – Present|
PROFESSIONAL MEMBERSHIPS
American Society of Transplantation and Cellular Therapy (ASTCT)
January 2019 – Present
Children’s Oncology Group (COG)
September 2018 – Present
American Society of Pediatric Hematology/Oncology (ASPHO)
July 2014 – Present|
American Academy of Pediatrics (ABP)
July 2011 – Present
Patient Reviews
⭐⭐⭐⭐⭐
Great bedside manner, he is great with kids! We loved having him on our sons team! We will forever be grateful to him as part of the OU children’s hem-onc staff!.
September 13th, 2019|